Obesity

"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Descriptor ID	D009765
MeSH Number(s)	C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
Concept/Terms	Obesity Obesity

Below are MeSH descriptors whose meaning is more general than "Obesity".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Nutrition Disorders [C18.654]
Overnutrition [C18.654.726]
Obesity [C18.654.726.500]
Pathological Conditions, Signs and Symptoms [C23]
Signs and Symptoms [C23.888]
Body Weight [C23.888.144]
Overweight [C23.888.144.699]
Obesity [C23.888.144.699.500]
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Physical Examination [E01.370.600]
Body Constitution [E01.370.600.115]
Body Weights and Measures [E01.370.600.115.100]
Body Size [E01.370.600.115.100.160]
Body Weight [E01.370.600.115.100.160.120]
Overweight [E01.370.600.115.100.160.120.699]
Obesity [E01.370.600.115.100.160.120.699.500]
Biological Sciences [G]
Physiological Phenomena [G07]
Body Constitution [G07.100]
Body Weights and Measures [G07.100.100]
Body Size [G07.100.100.160]
Body Weight [G07.100.100.160.120]
Overweight [G07.100.100.160.120.699]
Obesity [G07.100.100.160.120.699.500]

Below are MeSH descriptors whose meaning is related to "Obesity".

Below are MeSH descriptors whose meaning is more specific than "Obesity".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.

Bar chart showing 855 publications over 30 distinct years, with a maximum of 67 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	1	3
1997	2	2	4
1998	3	0	3
1999	5	1	6
2000	1	0	1
2001	5	4	9
2002	8	3	11
2003	13	6	19
2004	16	11	27
2005	18	4	22
2006	17	4	21
2007	19	10	29
2008	22	10	32
2009	21	13	34
2010	33	7	40
2011	37	7	44
2012	23	10	33
2013	49	18	67
2014	38	17	55
2015	43	18	61
2016	19	30	49
2017	42	13	55
2018	20	11	31
2019	29	11	40
2020	23	15	38
2021	8	17	25
2022	5	29	34
2023	5	20	25
2024	15	15	30
2025	3	4	7

Below are the most recent publications written about "Obesity" by people in Profiles.

Tamir TY, Chaudhary S, Li AX, Trojan SE, Flower CT, Vo P, Cui Y, Davis JC, Mukkamala R, Venditti FN, Hillis AL, Toker A, Vander Heiden MG, Spinelli JB, Kennedy NJ, Davis RJ, White FM. Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity. Mol Cell. 2025 Jun 05; 85(11):2211-2229.e8.

View in: PubMed
Rizo-Roca D, Henderson JD, Zierath JR. Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes. J Intern Med. 2025 Jun; 297(6):584-607.

View in: PubMed
Fath AR, Aglan A, Maron MS, Phillips JS, Maron BJ, Rowin EJ. Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy. Int J Cardiol. 2025 May 01; 426:133082.

View in: PubMed
Jonikas JA, Aranda F, Burke-Miller JK, Sabella K, Mullen MG, Davis M, Cook JA. Prevalence of chronic physical conditions and physical multimorbidity among young adults with serious mental health conditions. Psychiatr Rehabil J. 2025 Jun; 48(2):89-98.

View in: PubMed
Nandy A, Helderman RCM, Thapa S, Peck SH, Richards A, Jayapalan S, Narayani N, Czech MP, Rosen CJ, Rendina-Ruedy E. Enhanced fatty acid oxidation in osteoprogenitor cells provides protection from high-fat diet induced bone dysfunction. J Bone Miner Res. 2025 Feb 02; 40(2):283-298.

View in: PubMed
Cicu?ndez B, Mora A, L?pez JA, Curtabbi A, P?rez-Garc?a J, Porteiro B, Jimenez-Blasco D, Latorre-Muro P, Vo P, Jerome M, G?mez-Santos B, Romero-Becerra R, Leiva M, Rodr?guez E, Le?n M, Leiva-Vega L, G?mez-Lado N, Torres JL, Hern?ndez-Cosido L, Aguiar P, Marcos M, Jastroch M, Daiber A, Aspichueta P, Bola?os JP, Spinelli JB, Puigserver P, Enriquez JA, V?zquez J, Folgueira C, Sabio G. Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis. Nat Commun. 2025 Jan 13; 16(1):229.

View in: PubMed
Bea JW, Ochs-Balcom HM, Valencia CI, Chen Z, Blew RM, Lind KE, Caan BJ, Roe DJ, Rohan TE, Reeves KW, Manson JE, Ballinger T, Reding KW, Follis S, Ziller SG, Odegaard AO. Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence. JNCI Cancer Spectr. 2025 Jan 03; 9(1).

View in: PubMed
Cuccia AF, DiPietro L, Hayman LL, Whiteley JA, Napolitano MA. Longitudinal Changes in Cardiovascular Health Among Young Adults With Overweight and Obesity. J Cardiovasc Nurs. 2025 Jul-Aug 01; 40(4):E174-E181.

View in: PubMed
Pagoto S, Xu R, Bannor R, Idiong C, Goetz J, Fernandes D. Comparing Synchronous and Asynchronous Remotely Delivered Lifestyle Interventions: Protocol for a Randomized Noninferiority Trial. JMIR Res Protoc. 2024 Dec 19; 13:e65323.

View in: PubMed
Valdecantos MP, Ruiz L, Folgueira C, Rada P, Gomez-Santos B, Solas M, Hitos AB, Field J, Francisco V, Escalona-Garrido C, Zagmutt S, Calderon-Dominguez M, Mera P, Garcia-Martinez I, Maym?-Masip E, Grajales D, Alen R, Mora A, S?inz N, Vides-Urrestarazu I, Vilarrasa N, Arbones-Mainar JM, Zaragoza C, Moreno-Aliaga MJ, Aspichueta P, Fern?ndez-Veledo S, Vendrell J, Serra D, Herrero L, Schreiber R, Zechner R, Sabio G, Hornigold D, Rondinone CM, Jermutus L, Grimsby J, Valverde ?M. The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk. Nat Commun. 2024 11 28; 15(1):10342.

View in: PubMed

People

Explore

Similar Concepts

Top Journals